Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 88008

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
May 26, 2021
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
McKesson Corporation dba McKesson Drug Company

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distributed By: McKesson Corporation 4971 Southridge Blvd., Suite 101 Memphis, TN 38141 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 090, India NDC 63739-795-10

D-0630-2021
Recall number
D-0630-2021
Initiated
May 26, 2021
Classification
Class III
Status
Terminated
Quantity
210 cartons

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling; Wrong Barcode; error

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam

Code information

Lot: 0000124916 Exp. 09/30/2022

Distribution pattern

Nationwide in the US